Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M178Revenue (TTM) $M--Net Margin (%)--Altman Z-Score36.4
Enterprise Value $M145EPS (TTM) $-0.2Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)--Higher ROA y-yN
Price/Book5.110-y EBITDA Growth Rate %-8.6Quick Ratio19.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %0.7Current Ratio19.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-38.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-41.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M83.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CPRX is held by these investors:



CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
O'Keeffe Charles BDirector 2016-07-12Buy20,000$0.81161.73view
COELHO PHILIP HDirector 2016-06-17Buy15,000$0.76178.95view
DENKHAUS DONALD ADirector 2016-06-14Buy50,000$0.65226.15view
MCENANY PATRICK JPresident and CEO 2016-06-14Buy105,300$0.65226.15view
MCENANY PATRICK JPresident and CEO 2016-04-26Buy50,000$0.65226.15view
O'Keeffe Charles BDirector 2016-04-26Buy20,000$0.6253.33view
COELHO PHILIP HDirector 2016-03-17Buy10,000$1.06100view
O'Keeffe Charles BDirector 2016-03-16Buy10,000$1.1190.99view
Miller SteveCOO 2016-01-11Buy7,933$1.817.78view
O'Keeffe Charles BDirector 2016-01-08Buy5,000$1.949.28view

Press Releases about CPRX :

Quarterly/Annual Reports about CPRX:

News about CPRX:

Articles On GuruFocus.com
Catalyst Pharmaceuticals Receives 2017 Beacon Council Award for Contributions in Life Sciences & Hea May 12 2017 
Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Upda May 10 2017 
Catalyst Pharmaceuticals Announces Poster Presentation of MuSK-MG clinical data at the 13th Internat May 10 2017 
Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Thur May 02 2017 
Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored Trial of Firdapse® i Mar 15 2017 
Catalyst Pharmaceuticals to Present at the 29th Annual ROTH Conference Mar 10 2017 
Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Thu Mar 09 2017 
Catalyst Pharmaceuticals Insider Picks Up Shares of Company Oct 05 2015 
Piper Jaffray Remains Bullish on Catalyst Pharmaceuticals Following the Close of its Recent Public O Feb 17 2015 
Weekly CEO Buys Highlight: BH, CLMS, OPK, GPC, CPRX Jan 18 2015 

More From Other Websites
Catalyst Pharmaceuticals to Present at the Antiepileptic Drug and Device Trials XIV Symposium May 17 2017
Catalyst Pharmaceuticals Receives 2017 Beacon Council Award for Contributions in Life Sciences &... May 12 2017
Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call May 11 2017
Catalyst reports 1Q loss May 10 2017
Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate... May 10 2017
Catalyst Pharmaceuticals Announces Poster Presentation of MuSK-MG clinical data at the 13th... May 10 2017
What's in Store for Catalyst (CPRX) Stock in Q1 Earnings? May 02 2017
Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on... May 02 2017
Catalyst Pharmaceuticals and ZIOPHARM Oncology Bounce Up On FDA Phase News Mar 28 2017
Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting Stability Mar 21 2017
Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next Mar 16 2017
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial Results and Provides... Mar 15 2017
Catalyst Pharma Neuromuscular Drug Succeeds In Study Mar 15 2017
Here’s Why Traders Are Piling Into These Five Stocks Mar 15 2017
Catalyst Pharma shares jump 22% premarket on news of positive trial results for rare disease Mar 15 2017
Catalyst Pharma's neuromuscular drug succeeds in study Mar 15 2017
Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored Trial of Firdapse® in... Mar 15 2017
Catalyst Pharmaceuticals to Present at the 29th Annual ROTH Conference Mar 10 2017
Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on... Mar 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}